ABBV ▼ -0.1% - AbbVie Inc.
$ABBV - AbbVie Presents Long-Term RINVOQ® (upadacitinib) Data Showing Continued Repigmentation in Non-Segmental Vitiligo
01-OCT-2026 10:00 AM ET
Share this post
More filings for $ABBV
ABBV ▼ -0.0% - AbbVie Inc.Oct 1, 2026ABBV ▼ -1.2% - AbbVie Inc.Sep 30, 2026ABBV ▼ -1.2% - AbbVie Inc.Sep 30, 2026ABBV ▼ -0.2% - AbbVie Inc.Sep 22, 2026ABBV ▲ +0.5% - AbbVie Inc.Sep 22, 2026ABBV ▼ -0.7% - AbbVie Inc.Sep 21, 2026
View full $ABBV filing history →💬 Comments
Loading comments…
Leave a comment